Evidence-Based Medicine: When Are Statins Really Necessary?

Millions of Germans take statins due to high cholesterol levels, but questions are growing about whether the widespread prescription of these drugs is appropriate. A physician’s approach to prescribing statins hinges on whether a patient has already experienced a cardiovascular event, such as a heart attack or stroke, or if they are being considered for preventative treatment.

The benefit of statin leverage is well-established for individuals who have already suffered a heart attack or stroke. Data demonstrates a significantly reduced risk of subsequent events with statin therapy, making its use “sensible and strongly recommended” in these cases, according to medical professionals. However, the case for preventative statin use – prescribing the medication before any arteriosclerotic changes have been detected – is less clear.

Experts suggest attempting to reduce risk through non-pharmacological measures first in patients without existing cardiovascular disease. The benefit of proactively administering cholesterol-lowering drugs in these instances remains unproven. Statins function by inhibiting an enzyme, HMG-CoA reductase, in the liver, which is involved in cholesterol production. This process lowers LDL cholesterol levels in the blood, preventing the buildup of plaques in arteries that can lead to heart attack or stroke. The German Arzneiverordnungsreport 2023 indicates that statins are prescribed to up to nine million people in Germany.

Statins are among the most frequently prescribed medications globally, yet they are similarly subject to considerable skepticism. Research, including the Scandinavian Simvastatin Survival Study from 1994 involving 4,444 patients, has consistently demonstrated that lowering LDL cholesterol with statins reduces the risk of cardiovascular events. Despite being a proven therapy, statins are now available as affordable generics due to the expiration of their patent protection.

While effective, statins are not without potential side effects. Muscle pain, known as statin-myopathy, and muscle cramps are commonly reported. There is also evidence suggesting a slight increase in the risk of developing type 2 diabetes with statin use. The drugs also have an anti-inflammatory effect and can stabilize dangerous plaques in artery walls. A reduction of 1 mmol/l (approximately 40 mg/dl) in LDL cholesterol through statin treatment can reduce the risk of heart attack, stroke, or the necessitate for procedures like stents or bypass surgery by 20-25 percent annually.

The German Heart Foundation emphasizes that elevated LDL cholesterol is definitively linked to the development of arteriosclerosis, and that without cholesterol, arteriosclerosis cannot occur. However, the debate continues regarding the appropriate use of statins in primary prevention, highlighting the importance of an evidence-based approach to medical treatment and a careful consideration of individual patient risk factors.